Pol F Boudes - Net Worth and Insider Trading

Pol F Boudes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pol F Boudes owns 4 companies in total, including Galectin Therapeutics Inc (GALT) , Protalix BioTherapeutics Inc (PLX) , and CymaBay Therapeutics Inc (CBAY) among others .

Click here to see the complete history of Pol F Boudes’s form 4 insider trades.

Insider Ownership Summary of Pol F Boudes

Ticker Comapny Transaction Date Type of Owner
GALT Galectin Therapeutics Inc 2020-03-02 Chief Medical Officer
PLX Protalix BioTherapeutics Inc 2020-01-01 director
CBAY CymaBay Therapeutics Inc 2014-04-01 Chief Medical Officer
LIMIT LIMIT 2009-01-19 Chief Medical Officer

Pol F Boudes Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Pol F Boudes Ownership Network

Ownership Network List of Pol F Boudes

No Data

Ownership Network Relation of Pol F Boudes

Insider Network Chart

Pol F Boudes Owned Company Details

What does Galectin Therapeutics Inc do?

Who are the key executives at Galectin Therapeutics Inc?

Pol F Boudes is the Chief Medical Officer of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include Chief Financial Officer Jack W Callicutt , 10 percent owner 10x Fund, L.p. , and director & 10 percent owner Richard E Uihlein .

Galectin Therapeutics Inc (GALT) Insider Trades Summary

Over the past 18 months, Pol F Boudes made no insider transaction in Galectin Therapeutics Inc (GALT). Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 16,867 shares made by Kary Eldred , a net purchase of 26,300 shares made by Kevin D Freeman , and a net purchase of 14,500 shares made by Zordani Richard A. Jr. .

In summary, during the past 3 months, insiders sold 109,654 shares of Galectin Therapeutics Inc (GALT) in total and bought 45,269 shares, with a net sale of 64,385 shares. During the past 18 months, 134,654 shares of Galectin Therapeutics Inc (GALT) were sold and 58,667 shares were bought by its insiders, resulting in a net sale of 75,987 shares.

Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Galectin Therapeutics Inc Insider Transactions

No Available Data

Pol F Boudes Mailing Address

Above is the net worth, insider trading, and ownership report for Pol F Boudes. You might contact Pol F Boudes via mailing address: C/o Cymabay Therapeutics, Inc., 7575 Gateway Blvd., Suite 110, Newark Ca 94560.

Discussions on Pol F Boudes

No discussions yet.